Mobile Auto-Suggest on Steroids: Tap-Ahead Design Pattern

mobile-auto-suggest-on-steroids-tap-ahead-design-pattern-thumb

In contrast to desktop Web search, auto-suggest on mobile devices is subject to two additional limitations: typing avoidance and slower bandwidth. The new patent-pending design pattern, Tap-Ahead, uses continuous refinement to create an intuitive, authentically mobile auto-suggest solution. This helps dramatically reduce the amount of typing needed to enter queries, and utilizes slower mobile bandwidth in the most efficient manner. Using this novel design pattern, your customers can quickly access thousands of popular search term combinations by typing just a few initial characters.

US Patent #6677343: Substituted Piperazine Compounds

Key Ranolazine patent for CV Therapeutics/Gilead: a novel class of compounds that are useful in the treatment of cardiovascular diseases including arrhythmias, angina, congestive heart disease, and myocardial infarction.

US Patent #6180615: Propargyl Phenyl Ether A2A Receptor Agonists

Key CV Therapeutics/Gilead patent for A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart.

US Patent #6677336: Substituted Piperazine Compounds

Key Ranolazine patent for CV Therapeutics/Gilead: a novel class of compounds that are useful in the treatment of cardiovascular diseases including arrhythmias, angina, congestive heart disease, and myocardial infarction.